Guardian Pharmacy Services, Inc. (GRDN) Revenue History
Annual and quarterly revenue from 2018 to present
GRDN Revenue Over Time (2018–2025)
GRDN Revenue Growth History
7 of 7 years with positive growth- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- +16.3%
- FY2020 revenue growth
- +5.4%
- FY2021 revenue growth
- +7.6%
- FY2022 revenue growth
- +14.8%
- FY2023 revenue growth
- +15.1%
- FY2024 revenue growth
- +17.4%
- FY2025 revenue growth
- +17.9%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $336.6M | +2.2% |
| Q4 2025 | $397.6M | +17.4% |
| Q3 2025 | $377.4M | +20.0% |
| Q2 2025 | $344.3M | +14.8% |
| Q1 2025 | $329.3M | +19.6% |
| Q4 2024 | $338.6M | +20.5% |
| Q3 2024 | $314.4M | — |
| Q2 2024 | $300.0M | +18.4% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
GRDN's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
GRDN Revenue Analysis (2018–2025)
Current Revenue & Growth
As of June 22, 2026, Guardian Pharmacy Services, Inc. (GRDN) generated trailing twelve-month (TTM) revenue of $1.46 billion, reflecting modest growth of +2.2% year-over-year. The most recent quarter (Q1 2026) recorded $336.6 million in revenue, down 15.3% sequentially.
Historical Growth Trajectory
GRDN's 5-year compound annual growth rate (CAGR) stands at +14.5%, indicating consistent double-digit revenue growth. The 3-year CAGR of +16.8% exceeds the 5-year average, indicating an acceleration in the most recent period. Guardian Pharmacy Services, Inc.'s highest annual revenue of $1.45 billion was recorded in 2025, an all-time high.
Revenue by Segment
GRDN's revenue is primarily driven by Corporate Segment (100%). With over half of revenue concentrated in Corporate Segment, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including OMCL (+7.9% YoY), PINC (-16.2% YoY), and CVS (+7.6% YoY) — GRDN has outperformed the peer group in revenue growth. Compare GRDN vs OMCL →
GRDN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GRDNCurrent | $1.5B | +2.2% | +14.5% | 6.1% | |
 OMCL | $1.2B | +7.9% | +5.8% | 0.4% | |
 PINC | $1.0B | -16.2% | -4.9% | 0.1% | |
 CVS | $402.1B | +7.6% | +8.4% | 2.6% | |
 CCRN | $1.1B | -20.4% | +4.7% | -0.3% | |
 MCK | $403.4B | +12.4% | +11.1% | 1.6% |
GRDN Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.45B | +17.9% | $282.0M | 19.5% | $88.9M | 6.1% |
| 2024 | $1.23B | +17.4% | $244.4M | 19.9% | $-62,920,000 | -5.1% |
| 2023 | $1.05B | +15.1% | $208.3M | 19.9% | $40.9M | 3.9% |
| 2022 | $908.9M | +14.8% | $185.9M | 20.4% | $52.0M | 5.7% |
| 2021 | $792.1M | +7.6% | $161.3M | 20.4% | $30.1M | 3.8% |
| 2020 | $736.0M | +5.4% | $147.0M | 20.0% | $32.1M | 4.4% |
| 2019 | $698.3M | +16.3% | $143.5M | 20.5% | $34.1M | 4.9% |
| 2018 | $600.4M | - | $123.0M | 20.5% | $25.9M | 4.3% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GRDN — Frequently Asked Questions
Quick answers to the most common questions about buying GRDN stock.
Is GRDN's revenue growth accelerating or slowing?
GRDN revenue growth is slowing. TTM revenue is $1.5B, up +2.2% year-over-year — below the 5-year CAGR of +14.5%. The deceleration suggests maturing end-markets or increased competition.
What is GRDN's revenue history from 2018 to 2026?
Guardian Pharmacy Services, Inc. (GRDN) revenue history spans 2018 to 2026. TTM revenue as of 2026 is $1.5B, growing at +2.2% YoY. The 5-year CAGR is +14.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is GRDN's long-term revenue growth rate (CAGR)?
Guardian Pharmacy Services, Inc.'s 5-year revenue CAGR of +14.5% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +2.2% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for GRDN.
Why does GRDN's quarterly revenue fluctuate?
GRDN quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Guardian Pharmacy Services, Inc.'s revenue data from 2018 to 2026 shows full historical quarterly detail on this page.
How is GRDN's revenue distributed by segment?
GRDN reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does GRDN's revenue compare to industry peers?
Guardian Pharmacy Services, Inc. (GRDN) with TTM revenue of $1.5B and +2.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.